Management Team of Adamed Pharma S.A.

Graduate of the Foreign Trade Faculty at the Warsaw School of Economics, with a master’s degree in economics, and the Institute of Economics and Commercial Law at Taras Shevchenko National University of Kyiv.Before joining Adamed, he gained extensive professional experience working for financial institutions.

Read more

Between 1997 and 2008, he worked at the Pekao S.A. Central Brokerage House, where his career path led him from Analyst, through Project Manager and later Head of the Issue Preparation Team, to Director of the Capital Markets Department.

In 2008, he joined UniCredit CAIB Poland S.A., first as the Executive Director at the Investment Banking Division of Markets & Investment Banking and later as the Managing Director at the Investment Banking Division of UniCredit Group Corporate & Investment Banking.

He has worked for shareholders and management boards of sector-leading companies, including but not limited to: Netia, Globe Trade Centre, TVN, Cyfrowy Polsat, Dom Development, Mercor, Ferro, Tracktec, and Adamed. He has advised on the privatisation processes of Bank Pekao, the Warsaw Stock Exchange, Tauron Polska Energia, and PGE, to name a few.

At Adamed Pharma, he has been serving as the Managing Director since 2012. He is co-responsible for strategy development and supervision of its implementation. He oversees key projects and participates in making strategic investment decisions and their financing.

Tomasz Krzak has been with Adamed Pharma since 2014 and has served as a Member of the Management Board since January 2017. He is responsible for key strategic areas such as human capital development, organizational culture, the legal department, internal audit, corporate communications, cybersecurity, and administration.

Read more

He has over 20 years of experience in human resources management, organizational transformation, and employee relations – including negotiations with trade unions. He began his professional career at Śnieżka S.A. Paint and Varnish Factory, where he was involved in the company’s IPO on the Warsaw Stock Exchange. He then gained experience in international organizations – Fresenius Kabi and L'Oréal – where he held executive roles, overseeing markets in Poland, Eastern Europe, and the Baltic States.

He holds degrees in Law from the University of Silesia and in Journalism from the Jagiellonian University. He completed postgraduate studies in Human Resource Management at the Warsaw School of Economics and participated in prestigious executive programs, including the Senior Executive Programme at London Business School and the People, Culture & Performance program in Silicon Valley at Stanford Graduate School of Business.

He is passionate about creating an engaging work environment based on trust, values, and shared responsibility. He believes that the strength of any organization lies in the potential and commitment of its people.

Graduate of the Department of Pharmacy, Jagiellonian University Medical College in Krakow, with first-degree specialization in retail pharmacy. Her career has been linked to the pharmaceutical industry for over 15 years. She has built her professional experience both in original and generic pharmaceutical companies (Servier, Ipsen, Adamed,

Read more

Egis), originally in the sales area, then working her way up into operational marketing and business development.

Sylwia Berdzik-Kalarus has been working for Adamed since 2013. She initially built the Strategic Marketing structures and since 2016 she has been responsible for the entire Adamed Business Development and Product Portfolio Management Department. In March 2021, as Director of Commercial Affairs and Business Development, she took over the management of commercial operations both on the Polish and foreign markets.

She is co-responsible for the development and deployment of Adamed's global strategy, including the pipeline creation, and for the company's successful adaptation to the changing market environment. Among other fields of expertise, she is in charge of operational and strategic marketing, sales and distribution management both in Poland and on international markets. The scope of her professional duties also includes managing the Innovation Department, with coordination and creation of development strategies, and commercialization of innovative molecules in the therapeutic areas of CNS, oncology and diabetology.

Graduate of the Wroclaw University of Economics and Business, where he was awarded his PhD in Economics in 2002. Holder of a scholarship in Project Planning and Analysis at the University of Bradford, granted by the UK Government (2005). In 2000–2009, a university lecturer at the Wroclaw University of Economics and Business, as well

Read more

as WSB University in Wrocław, among others.

An experienced manager, he has worked in the pharmaceutical sector since 2003. In 2006–2008, he held the role of Managing Director of the Polish-German Research Association (EEIG). Since 2017, he has been a Member of the Board of Directors at Davipharm. In 2018–2020, he held the role of Member of the Economic Council of the Lodz Province.

Bartłomiej Rodawski has authored more than a dozen articles on supply chain management in the pharmaceutical sector, as well as a report called: “Supply Chain Management in the Pharmaceutical Sector in Poland in 2008” which was published by PMR Institute. Throughout his professional career, he has run analytical, training and implementation projects in the pharmaceutical, FMCG, logistics and service sectors.

He has worked at Adamed since 2009. Since 2013, he has been a Member of the Management Board and Chief Operating Officer. He is in charge of the co-development and implementation of the strategy for the development of broadly understood supply chain, including production, quality, logistics, and technology.

A graduate in Biotechnology from the Faculty of Chemistry at Gdańsk University of Technology. Holds an Executive MBA from Kozminski University in Warsaw.
She also completed postgraduate studies in Business Management and Project Management at WSB University in Gdańsk.

Read more

She has been working in the R&D field for over 20 years. Between 2002 and 2014, she worked at ZF Polpharma S.A., including roles as R&D Project Team Coordinator, Project Manager in the Regulatory Affairs Department, and Head of Pharmaceutical Analysis Development. During this time, she led both national and global initiatives, such as harmonizing registration documentation for WZF Polfa Warsaw products and implementing European R&D standards in Kazakhstan’s largest local drug factory.

She has been with Adamed Pharma since 2015. Initially, she served as Director of the Generic Business Division. Since 2018, she has held the position of Director of Research and Development. She is jointly responsible for shaping and implementing R&D strategy, including expanding the company’s product portfolio by managing the full scope of R&D projects — from idea to marketing authorization — across over 90 global markets. Her responsibilities include overseeing research and development laboratories (analytical, organic synthesis, preformulation, formulation, inhalation drug development), R&D pilot-scale production, clinical research teams, and the Regulatory Affairs & Pharmacovigilance Department.

Since April 2022, she has been a Member of the Management Board at Adamed Pharma S.A.

Completed Management Education at London Business School. Graduate of ACCA studies and MBA program at the Warsaw University of Technology run in cooperation with London Business School, HEC Paris, and the Norwegian School of Economics.
Involved with Adamed Pharma since 2023. Prior to joining the company, he served as the CFO for

Read more

the CFO for business operations at Polpharma Group, with roles as a member of the company’s Management Board and Supervisory Board. He was responsible for the creation and development of the entire function of finance for business operations at Polpharma. During that time, he also held the positions of Vice-President for Finance at Polfa Lublin, Member of the Supervisory Board of Herbapol Lublin, and the Polpharma Scientific Foundation. In addition, throughout his professional career, he worked as an advisor at Belvedere Group and SenseMedConcept, with responsibility for the implementation of systems and establishment of reporting standards and managerial dashboards.

At Adamed Pharma, he is in charge of the Financial Area, with duties including the formulation and implementation of a financial strategy for the entire organization. In collaboration with the Management Team and the Supervisory Board, he develops and implements Adamed’s growth strategy for the Polish and foreign markets.